Axsome Therapeutics, Inc 10-K for FY2025
Axsome Therapeutics, Inc. (AXSM)
10-K
2026-02-23
For: 2025-12-31
View Original
Added on
April 09, 2026
About this 10-K
Axsome Therapeutics, Inc filed this 10-K on February 23, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $638.5M
- up 65.5% from $385.69M a year earlier
- Net loss
- $183.17M
- compared with a net loss of $287.22M a year earlier
- Diluted EPS
- -$3.68
- compared with -$5.99 a year earlier